$272.69
+
$2.91 (1.08%)
End-of-day quote: 05/15/2024
NasdaqGS:UTHR
United Therapeutics Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | NYSE | Outperform | $152.67 | $174.55 | 0.00% | 3 | $364.32B |
| AMGN | Amgen | NasdaqGS | Outperform | $319.04 | $303.65 | 0.00% | 8 | $167.05B |
| PFE | Pfizer | NYSE | Outperform | $28.82 | $32.87 | 0.00% | 6 | $160.82B |
| VRTX | Vertex Pharmaceuticals Inc | NASDAQ | Outperform | $437.49 | $457.59 | 0.00% | 11 | $110.60B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $978.21 | $961.26 | 0.00% | 8 | $106.23B |
| GSK | GSK | LSE | Outperform | £18.13 | £17.30 | 0.00% | 12 | £73.81B |
| GILD | Gilead Sciences Inc | NASDAQ | Outperform | $67.01 | $87.82 | 0.00% | 14 | $84.28B |
| BIIB | Biogen | NasdaqGS | Outperform | $235.32 | $299.62 | 0.00% | 13 | $33.03B |
| BAYN | Bayer | XTRA | Hold | 29.33€ | 45.15€ | 0.00% | 4 | 28.71€B |
| CE | Celanese | NYSE | Hold | $158.58 | $148.23 | 0.00% | 18 | $17.44B |
| VTRS | Viatris Inc | NASDAQ | Hold | $11.07 | $11.73 | 0.00% | 5 | $13.32B |
| LQDA | Liquidia | NasdaqCM | Outperform | $12.29 | $19.71 | 0.00% | 2 | $913.54M |
